Published in Eur Heart J on May 01, 1994
A coronary-care unit in the routine management of acute myocardial infarction. Lancet (1967) 11.31
Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ (1994) 9.91
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med (1988) 8.90
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Cardiopulmonary resuscitation skills of preregistration house officers. Br Med J (Clin Res Ed) (1985) 8.45
Extensive genome-wide linkage disequilibrium in cattle. Genome Res (2000) 8.31
The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) (1985) 7.53
Total excitation of the isolated human heart. Circulation (1970) 7.04
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ (1995) 6.28
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res (2003) 5.39
Anomalous increase in carbon capacitance at pore sizes less than 1 nanometer. Science (2006) 4.30
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Problems in evaluating coronary care units. Their responsibilities and their relation to the community. Am J Cardiol (1967) 3.70
A milestone for myocardial infarction. BMJ (1988) 3.42
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation (1993) 3.13
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med (1999) 2.99
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation (1997) 2.95
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation (1988) 2.86
Ventricular fibrillation complicating acute myocardial infarction. Lancet (1968) 2.80
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Chlamydia pneumoniae and coronary heart disease. BMJ (1997) 2.73
Colour Doppler flow mapping. BMJ (1990) 2.69
Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol (1992) 2.62
Materials science. True performance metrics in electrochemical energy storage. Science (2011) 2.58
Left atrial appendage: structure, function, and role in thromboembolism. Heart (1999) 2.52
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Treatable arrhythmias in cardiac arrests seen outside hospital. Lancet (1992) 2.46
Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing. BMJ (1992) 2.42
Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol (1991) 2.42
Pathophysiology and prevention of atrial fibrillation. Circulation (2001) 2.31
Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart (2002) 2.23
The QT interval. Prog Cardiovasc Dis (2001) 2.22
Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects. Pacing Clin Electrophysiol (1994) 2.21
Atrial arrhythmias. Lancet (1993) 2.13
Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation (2001) 2.11
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol (1990) 2.05
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Natural history of unstable angina. Lancet (1972) 2.03
The Family Health Project: psychosocial adjustment of children whose mothers are HIV infected. J Consult Clin Psychol (1998) 2.03
The rhythm of the heart in active elderly subjects. Am Heart J (1980) 2.02
Observations on cardiac arrythmias during laparoscopy. Br Med J (1972) 2.02
Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf (2001) 2.02
Complete denervation of the heart in a child with congenital long QT and deafness. Am J Cardiol (1988) 2.00
Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut (2005) 2.00
High rate capabilities Fe3O4-based Cu nano-architectured electrodes for lithium-ion battery applications. Nat Mater (2006) 1.99
Cardiac arrhythmia suppression trial and flecainide. Lancet (1989) 1.98
Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone. Lancet (1989) 1.96
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med (1999) 1.92
Components of heart rate variability--what they really mean and what we really measure. Am J Cardiol (1993) 1.91
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation (1977) 1.87
Sick sinus syndrome: experience of a cardiac pacemaker clinic. Br Med J (1974) 1.86
Surgical complications with open treatment of mandibular condylar process fractures. J Oral Maxillofac Surg (2000) 1.81
Early neurological complications of coronary artery bypass surgery. Br Med J (Clin Res Ed) (1985) 1.78
Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol (1992) 1.74
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J (1980) 1.71
Artificial pacing in management of complete heart block complicating acute myocaerdial infarction. Br Med J (1968) 1.71
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70
Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res (1987) 1.69
Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect (1995) 1.69
Fine-mapping of quantitative trait loci by identity by descent in outbred populations: application to milk production in dairy cattle. Proc Natl Acad Sci U S A (1999) 1.67
Hybridization of 2,659 Clostridium perfringens isolates with gene probes for seven toxins (alpha, beta, epsilon, iota, theta, mu, and enterotoxin) and for sialidase. Am J Vet Res (1996) 1.67
Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet (1988) 1.65
Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol (2000) 1.65
Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ Res (1978) 1.64
Classification of atrial fibrillation. Pacing Clin Electrophysiol (1997) 1.63
Laplacian electrograms and the interpretation of complex ventricular activation patterns during ventricular fibrillation. J Cardiovasc Electrophysiol (2000) 1.63
QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J (1996) 1.63
Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques. Eur Heart J (1989) 1.59
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59
Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol (1992) 1.58
3-Hydroxybenzo[a]pyrene in the urine of workers with occupational exposure to polycyclic aromatic hydrocarbons in different industries. Occup Environ Med (2007) 1.57
Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res (1994) 1.55
Comparison of arrhythmia computer and conventional monitoring in coronary-care unit. Lancet (1975) 1.55
Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation (1995) 1.55
Morphology and electrophysiology of the mammalian atrioventricular node. Physiol Rev (1988) 1.54
Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation (1989) 1.53
Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation (1996) 1.51
Limitations of rate response of an activity-sensing rate-responsive pacemaker to different forms of activity. Pacing Clin Electrophysiol (1988) 1.51
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50